학술논문

Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation
Document Type
Journal
Source
ANNALS OF ONCOLOGY; SEP 2022, 33 7, pS1408-pS1409, 2p. Supplement: 7
Subject
Language
English
ISSN
15698041